The healthcare landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike subcutaneous injections, this technique offers a simpler way to provide GLP-1 medications. These patches steadily release the drug through the epidermis offering a s